← Back to headlines
Abbott Laboratories Beats Q1 Revenue, Lowers FY26 Profit Outlook
Abbott Laboratories reported its first-quarter earnings, surpassing revenue estimates while its non-GAAP EPS was in line with expectations. However, the company also lowered its adjusted profit outlook for fiscal year 2026.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
